Improving the clinical and cost effectiveness of medicines (2018)

East Riding of Yorkshire CCG

Introduction

The NHS faces unprecedented levels of pressure, driven by: an ageing population; increase in long-term conditions; rising costs; public expectations and a challenging financial environment. It is increasingly important that East Riding of Yorkshire Clinical Commissioning Group (CCG) collaborate with their partners to achieve efficiencies, whilst improving quality and patient experience.

In 2015-16, the CCG was under significant pressure to work within its financial allocation and needed to address this financial situation urgently if it was to maintain control over commissioning decisions and avoid reductions in essential services later. The prescribing budget alone was forecasting c£1.7m – £2m deficit. Compared to the 10 Office for National Statistics, the CCG spent £2m more than the upper quartile and could save in excess of £9m if it moved to best in class.

The challenges facing the CCG were:

  • High levels of prescribing cost, c£2m more than the upper quartile
  • High levels of drugs wasted, c£1.5m in unused medicines
  • Variation in clinical engagement
  • Not all practices signed up to the medicines management plan, along with a high number of dispensing practices

How was the project established? / How is it currently being established?

The North of England Commissioning Support (NECS) Medicines Optimisation team produced a prescribing recovery plan in late 2015/2016 to then start late 2015/2016 and run into 2016/2017. This was based on reviewing prescribing data including the information on the PrescQIPP website. The prescribing recovery plan identified specific areas that could release an estimated £6 million of potential prescribing savings. Following a 12-week consultation period with stakeholders, patients and members of the public, a range of options to reduce prescribing costs, over and above the previous medicines management work plan agreed at the beginning of the 2015/2016 financial year, was then agreed via the CCG Service Redesign and Commissioning Committee and the CCG Council of Members. This supported ten actions across a broad spectrum of medicines management areas:

1. Prescribing the best value for money option to maximise value for money

GPs throughout East Riding of Yorkshire were encouraged and supported to prescribe 'best buy' medication for their patients.

  • Changing formulation to the least expensive (where the active ingredients are the same)
  • Optimising the use of Hull and East Riding Prescribing Committee (HERPC) joint formulary
  • A small selection of “branded generics” where bioequivalence was demonstrated, potential savings are high, supply is assured and prices are guaranteed until 2019
  • Changing blood glucose testing meters to one of the three formulary approved fully ISO compliant versions (Type 2 diabetes)

2. Asking people to buy their items over the counter

The CCG carried out a large-scale marketing communications campaign aimed at the local public, encouraging them to self-care, be prepared and have a well-stocked medicine cabinet with essentials such as:

  • Simple short term analgesia
  • Cough and cold treatments
  • Vitamins and health food supplements
  • Some gluten free foods (following a reduction to the number of units and range of products available on prescription)
  • Oral nutritional supplements reviews and promoting a 'food first approach'

3. Reducing waste and improving safety

The CCG estimated that unused medicines cost them around £1.5 million each year. As a result, in 2016/17, the CCG implemented a number of initiatives including: 

  • Optimising repeat prescribing systems, including the implementation of the OptimiseRx clinical decision aid i.e. delivering patient-specific best practice, safety and cost-saving guidance to local prescribers. OptimiseRx combines evidence-based best practice, safety and cost-effective prescribing messages, delivered in real time at the point of care. Innovative and intelligent, OptimiseRx is seamlessly integrated with the prescribing workflow of the clinical system, providing healthcare professionals with guidance based on individual patient record.
  • Reviewing dispensing processes
  • Undertaking a marketing communications campaign encouraging patients to only order the repeat medicines they need.

The NECS Medicines Optimisation team reprioritised the prescribing recovery plan areas and worked with individual practices to implement the plan. This work was completed under appropriate protocols, and the trusted relationship between the practices and the NECS Medicines Optimisation team was integral to the success of the plan. In addition, the CCG GP prescribing lead provided strong and essential clinical leadership in implementing the plan. The CCG also produced a 'Managing Potentially Excessive or Inappropriate Prescribing' policy and worked with the Local Medical Committee on agreeing approaches to effect changes when it they considered it relevant to the policy.

  • The prescribing recovery plan was supported by a comprehensive communications and engagement strategy that included seeking views via a survey, meetings with local patient groups, media management and public awareness campaigns. These campaigns included messages about waste management, costs of prescribing paracetamol compared to over the counter, encouraging patients to self-manage where appropriate and seeking advice from pharmacies.
  • GP Practices and community Pharmacies received leaflets giving information on the changes and CCG contact details, to give to patients who were concerned about any changes to their medication. This ensured a consistent message from the CCG to patients and minimised the workload for practices in responding to patient concerns.

The CCG has organisationally owned the prescribing recovery plan and completed ongoing scrutiny on its performance via the CCG Delivery Group. This has also provided an organisational audit trail and the platform for continuously targeting opportunities.

Who are the main beneficiaries of the project? How would they benefit?

The CCG goals were to reduce costs and improve patient safety, and in addition:

  • GPs to prescribe best value for money medicines to maximise value for money
  • Patients to self-care, and be prepared with a well-stocked medicine cabinet with medicines bought over the counter as opposed to free prescriptions, saving the NHS money
  • Patients to check their repeat prescriptions and only order medicines when needed, to avoid medicine waste
  • OptimiseRx clinical decision software implemented to facilitate safe and cost effective prescribing
  • A dedicated CCG GP prescribing lead to give strong and essential clinical leadership in implementing the initiatives
  • NECS Medicines Optimisation team, to support GP practices in the rolling out the initiatives

PrescQIPP 'cost avoidance' information was used in monthly reports back to the CCG and GP practices. Outcomes from implementation of the prescribing recovery plans included 'cost avoidance' reductions from baseline in the following areas:

  • 'Call to action' area (cheaper medication where the active ingredients were the same)
  • Blood Glucose Test strips – i.e. increasing use of 'low cost' blood glucose test strips.
  • Self-care (all) - over the counter (OTC) medication for the management of minor ailments – An 'over the counter' campaign to increase people buying rather than getting on prescription
  • Gluten free items excl. all bread, flour & mixes cost per 1,000 patients
  • Gluten free cost per 1,000 patients
  • SIP (nutritional supplement) feeds
  • Pharmaceutical specials
  • 'Cost effective drug choice areas'
    • Low cost drugs for urinary incontinence
    • Topical emollients choice
  • PrescQIPP DROP-List (Drugs to Review for Optimised Prescribing)
  • Medicines waste campaign

Outcomes: 

  • 100% sign up to the plans
  • Improved and strengthened relationships with stakeholders in overcoming challenges
  • Agreement of policy on inappropriate and excessive prescribing
  • Comprehensive publicity campaign
  • A reduction in inappropriate antibiotic prescribing
  • Continued reductions in C. Difficile infections

The value created:

  • The 2017-18 plans was for £1.7m but it actually achieved £3.7m

What were the main outcomes and / or achievements of the project?

The initiatives have seen a significant reduction in prescribing costs. In 2016-17, the CCG saw a reduction of 0.9% in prescribing costs, this despite two successive years of increasing costs of circa 4%. This equates to a total identified QIPP saving of £1.6 million included within wider cost mitigation of £2.6m. In the following year (2017-18) the CCG achieved an additional £3.7 million costs saving. This ultimately will lead to greater stability in the commissioning of local services to patients in East Riding of Yorkshire area. This should also lead to improved patient experiences and create value for taxpayers and patients alike.

The CCG has also maintained prescribing quality and outcomes within the prescribing recovery plans. An example is the reduction in prescribing antibiotics associated with health care related infections that has contributed to a continued reduction in Clostridium difficile levels 66 against a target of 85 in 2016-17 and 56 against a target of 85 in 2017-18. In addition, latest prescribing information for 2017-18 shows we have met the NHS England CCG Improvement & Assessment Framework antibiotic indicator targets for reducing the prescribing of broad-spectrum antibiotics and the number of antibiotics prescribed.

Throughout the project engagement with stakeholders was particularly important to ensure they understood and bought into the changes to help influence the outcomes.

In December 2015, the CCG launched a prescribing survey with stakeholders, patients, members of the public, GPs, pharmacists and the Local Medical Council to:

  • Assess levels of support within our community for the initiatives we intended to implement
  • Encourage people to suggest how we can support them, should they be directly affected
  • Ask people to put forward other ideas for savings we could implement

486 people responded to the survey both online and handwritten. 59 letters were also received from patients and stakeholders.

Survey highlights included:

  • 79% agreed with our plans to prescribe the best buy option to maximise value for money
  • 72% agreed with our plans to ask people to buy their items over the counter
  • 97% agreed with our plans to reduce waste and improve safety

Because of feedback, a number of changes to our original plans were agreed:

  • The LMC supported a communication campaign encouraging adults and children to buy their own medication where appropriate, reducing the need for a GP appointment and saving NHS money on free prescriptions.
  • Responding to concerns re gluten-free foods the CCG agreed a compromise to restrict prescribing to 8 units per month for basic bread loaves, flour and flour mix only.